BURLINGTON, ON, Feb. 24, 2022 /CNW/ - EcoSynthetix Inc.
(TSX: ECO) ("EcoSynthetix" or the "Company"), a
renewable chemicals company that produces a portfolio of
commercially proven bio-based products, today announced its
financial and operational results for the three months (Q4 2021)
and twelve months (FY 2021) ended December
31, 2021. Financial references are in U.S. dollars unless
otherwise indicated.
Highlights
(Comparison periods in each case are
the three months ended December 31,
2020)
- Recorded net sales of $4.9
million in Q4 2021, up 46%, due to higher volumes of 20% and
higher average selling price of 26%
- Received an annual contract renewal and purchase orders for
continuous monthly volumes for the Company's DuraBind™ resin from a
global top 15 wood composites manufacturer and leading
international retailer
- Awarded a Platinum designation by EcoVadis, a globally
recognized agency for business sustainability ratings of supply
chains, with a sustainability score for the Company within the top
1% of 85,000 companies rated
- Announced the Company expects to achieve climate positive
status in 2022, with a 1:1 carbon cover of the carbon emissions
associated with the business due to the carbon footprint reductions
by customers enabled through the use of EcoSynthetix' products
- Gross profit of $1.0 million, up
49%, in Q4 2021, enabled by the diversification of revenue mix
- Recorded Adjusted EBITDA loss of $0.3
million in Q4 2021, a change of $0.2
million, compared to the prior period
- Recorded positive cash flow from operations of $0.5 million in FY 2021, the third consecutive
year of positive cash flow from operations
- Purchased and cancelled 91,600 common shares in Q4 2021, and
292,000 in FY 2021, under the normal course issuer bid for total
consideration of $0.4 million and
$1.2 million respectively
- Maintained a strong balance sheet with cash of $42.2 million as at December 31, 2021
"Our commercial strategy of diversifying into the wood
composites and personal care markets beyond graphic paper continued
to gain momentum as topline sales grew 46% in the fourth quarter,"
said Jeff MacDonald, CEO of
EcoSynthetix. "Our bio-based polymers offer significant advantages
over traditional petroleum-based resins. The performance and value
of our biopolymers are competitive to the conventional
alternatives. Plus, our products offer manufacturers significant
sustainability benefits, such as reducing the carbon footprint for
wood composites manufacturers where binders are a leading source of
carbon intensity in their supply chain. We are commercial with two
of the top 15 global wood composites manufacturers. Growing within
these accounts, both in the volume used on the existing lines and
expanding into new mills they operate are our near-term commercial
priorities. The advantages our biopolymers offer across each of our
three end markets and the market dynamics as customers, retailers
and manufacturers pursue more sustainable and healthier
alternatives position us to deliver long-term, sustainable
growth."
Financial Summary
Net Sales
Net sales were $4.9 million and
$18.2 million for Q4 2021 and FY
2021, respectively, compared to $3.3
million and $13.7 million in
the corresponding periods in 2020. The increase in the quarter was
due to higher sales volumes which increased sales $0.6 million, or 20%, enabled by the continued
diversification of the Company's revenue mix from increased sales
of DuraBind™ and improved volumes in paper and paperboard, as
well as a higher average selling price which increased sales by
$0.9 million, or 26%. The 33%
increase in the FY period was due to higher sales volumes which
increased sales $2.5 million, or 18%,
and a higher average selling price which increased sales by
$2.0 million, or 15%.
Gross Profit
Gross profit was $1.0 million and
$4.0 million for Q4 2021 and FY 2021,
respectively, compared to $0.7
million and $2.7 million in
the corresponding periods in 2020. The increase in both periods was
primarily due to higher sales volumes and a higher average selling
price partly offset by higher manufacturing costs.
Gross profit as a percentage of sales was 20.7% and 21.9% for Q4
2021 and FY 2021, respectively, compared to 20.3% and 20.0% in the
corresponding periods in 2020. The increases were primarily due to
a higher average selling price offset by higher costs of
manufacturing during both periods. Gross profit as a percentage of
sales adjusted for manufacturing depreciation was 24.8% and 26.2%
for Q4 2021 and FY 2021, respectively, compared to 27.2% and 26.0%
for the corresponding periods in 2020. The decrease in quarterly
period was primarily due to higher manufacturing costs partially
offset by a higher average selling price.
Selling, General and Administrative
Selling, general and administrative expenses (SG&A) were
$1.5 million and $5.4 million for Q4 2021 and FY 2021,
respectively, compared to $1.2
million and $4.3 million for
the corresponding periods in 2020. The increase in SG&A in the
quarterly period was primarily due to lower payments received under
the Canadian Emergency Wage Subsidy program (CEWS) of $0.1 million and a $0.1
million increase in salaries and benefits. The increase in
the FY period was primarily due to an increase in the provision for
variable based compensation of $0.4
million, lower payments received under CEWS of $0.2 million, an increase in share-based
compensation of $0.2 million and an
increase in salaries and benefits of $0.2
million.
Research and Development
Research and development (R&D) costs were $0.5 million and $1.8
million for Q4 2021 and FY 2021, respectively, compared to
$0.3 million and $1.4 million for the corresponding periods in
2020. R&D expense as a percentage of sales was 10% for both the
Q4 2021 and FY 2021 periods, respectively, compared to 8% and 10%
in the corresponding periods in 2020. The Company's R&D efforts
continue to focus on further enhancing value for its existing
products and expanding addressable opportunities.
Adjusted EBITDA1
Adjusted EBITDA loss was $0.3
million and $0.9 million for
Q4 2021 and FY 2021, respectively, compared to $0.1 million and $0.8
million in the corresponding periods in 2020. Adjusted
EBITDA loss increased during both periods as higher gross profit
was offset by higher operating costs.
Net Loss
Net loss was $0.9 million, or
$0.02 per common share, and
$3.2 million, or $0.06 per common share, for Q4 2021 and FY 2021,
respectively, compared to $0.7
million, or $0.01 per common
share, and $2.4 million, or
$0.04 per common share, for the
corresponding periods in 2020. The increases in both periods were
primarily due to higher loss from operations and lower interest
income due to lower interest rates on cash and short-term
investments.
Liquidity
Cash on hand was $42.2 million as
at December 31, 2021, compared to
$42.0 of cash on hand and short-term
investments as at December 31, 2020.
The Company purchased and cancelled 91,600 common shares for
consideration of $0.4 million under
the normal course issuer bid in Q4 2021 and 292,000 common shares
for consideration of $1.2 million in
FY 2021.
Notice of Conference Call
EcoSynthetix will host a conference call Friday, February 25, 2022, at 8:30 AM ET to discuss its financial results.
Jeff MacDonald, CEO, and
Robert Haire, CFO, will co-chair the
call. All interested parties can join the call by dialling (416)
764-8659 or (888) 664-6392 with the conference identification of
72729846. Please dial in 15 minutes prior to the call to secure a
line. A live audio webcast of the conference call will also be
available at www.ecosynthetix.com. The presentation will be
accompanied by slides, which will be available via the webcast link
and the Company's website. Please connect at least 15 minutes prior
to the conference call to ensure adequate time for any software
download that may be required to join the webcast.
1Non-IFRS Financial Measures
This press release makes reference to certain non-IFRS measures.
These non-IFRS measures are not recognized measures under IFRS, do
not have a standardized meaning prescribed by IFRS and are
therefore unlikely to be comparable to similar measures presented
by other companies. Rather, these measures are provided as
additional information to complement those IFRS measures by
providing a further understanding of results of operations of
EcoSynthetix from management's perspective. Accordingly, they
should not be considered in isolation nor as a substitute for
analysis of the financial information of EcoSynthetix reported
under IFRS. The Company uses non-IFRS measures such as Adjusted
EBITDA to provide investors with a supplemental measure of
operating performance and thus highlight trends in its core
business that may not otherwise be apparent when relying solely on
IFRS financial measures. Management also believes that securities
analysts, investors and other interested parties frequently use
non-IFRS measures in the evaluation of issuers. Management also
uses non-IFRS measures in order to facilitate operating performance
comparisons from period to period, prepare annual operating budgets
and assess the Company's ability to meet its capital expenditure
and working capital requirements.
Adjusted EBITDA is not a measure recognized under IFRS and does
not have a standardized meaning prescribed by IFRS. See "IFRS and
Non-IFRS Measures." The Company presents Adjusted EBITDA because
the Company believes it facilitates investors' use of operating
performance comparisons from period to period and company to
company by backing out potential differences caused by variations
in capital structures (affecting relative interest expense), the
book amortization of intangibles (affecting relative amortization
expense) and the age and book value of property and equipment
(affecting relative depreciation expense). The Company also
presents Adjusted EBITDA because it believes it is frequently used
by securities analysts, investors and other interested parties as a
measure of financial performance. Adjusted EBITDA as presented
herein are not recognized measures under IFRS and should not be
considered as an alternative to operating income or net income as
measures of operating results or an alternative to cash flows as
measures of liquidity. Adjusted EBITDA is defined as consolidated
net income (loss) before net interest expense, income taxes,
depreciation, amortization, other non-cash expenses and charges
deducted in determining consolidated net income (loss).
The following table reconciles net loss to Adjusted EBITDA loss
for the three and twelve months ended December 31, 2021 and December 31, 2020:
|
Three months
ended
December 31, 2021
|
Three months
ended
December 31, 2020
|
Twelve months
ended
December 31, 2021
|
Twelve months
ended
December 31, 2020
|
Net
Loss
|
(936,867)
|
(705,904)
|
(3,179,740)
|
(2,402,094)
|
Depreciation
|
324,387
|
391,098
|
1,380,832
|
1,439,504
|
Share-based
Compensation
|
289,998
|
277,394
|
937,260
|
783,822
|
Interest
Income
|
(10,499)
|
(86,222)
|
(62,426)
|
(605,497)
|
Adjusted EBITDA
loss
|
(332,981)
|
(123,634)
|
(924,074)
|
(784,265)
|
About EcoSynthetix Inc. (www.ecosynthetix.com)
EcoSynthetix, a 2022 climate positive company, offers a range of
sustainable engineered biopolymers that allow customers to reduce
their use of harmful materials, such as formaldehyde and
styrene-based chemicals. The Company's flagship products,
DuraBind™, Bioform™, and EcoSphere®, are used to manufacture wood
composites, personal care, and paper and packaging, and enable
performance improvements, economic benefits and carbon footprint
reduction. The Company is publicly traded on the Toronto Stock
Exchange (T:ECO).
Forward-Looking Statements
Certain statements in this Press Release constitute
"forward-looking" statements that involve known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance, objectives or achievements of the Company, or industry
results, to be materially different from any future results,
performance, objectives or achievements expressed or implied by
such forward looking statements. The forward-looking statements in
this Press Release include, but are not limited to, statements
regarding the Company's plans to execute its commercial strategy,
deliver meaningful growth across all three product categories,
convert high-value strategic prospects into customers, and other
statements regarding the Company's plans and expectations in 2022.
These statements reflect our current views regarding future events
and operating performance and are based on information currently
available to us, and speak only as of the date of this Press
Release. These forward-looking statements involve a number of
risks, uncertainties and assumptions and should not be read as
guarantees of future performance or results, and will not
necessarily be accurate indications of whether or not such
performance or results will be achieved. Those assumptions and
risks include, but are not limited to, the Company's ability to
successfully allocate capital as needed and to develop new
products, as well as the fact that our results of operations and
business outlook are subject to significant risk, volatility and
uncertainty. Many factors could cause our actual results,
performance or achievements to be materially different from any
future results, performance or achievements that may be expressed
or implied by such forward-looking statements, including the
factors identified in the "Risk Factors" section of the Company's
Annual Information Form dated February 24,
2022. Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
statements prove incorrect, actual results may vary materially from
those described in this Press Release as intended, planned,
anticipated, believed, estimated or expected. Unless required by
applicable securities law, we do not intend and do not assume any
obligation to update these forward-looking statements.
EcoSynthetix
Inc.
|
|
|
Consolidated
Balance Sheets
|
|
|
(expressed in US
dollars)
|
|
|
|
|
|
|
|
|
|
December 31,
2021
|
December 31,
2020
|
Assets
|
|
|
|
|
|
Current
assets
|
|
|
Cash
|
42,226,816
|
16,637,161
|
Short-term
investments
|
-
|
25,344,575
|
Accounts
receivable
|
1,912,390
|
1,794,594
|
Inventory
|
2,073,800
|
2,134,389
|
Government grants
receivable
|
6,676
|
122,218
|
Prepaid
expenses
|
91,930
|
69,633
|
|
46,311,612
|
46,102,570
|
|
|
|
Non-current
assets
|
|
|
Property, plant and
equipment
|
4,670,089
|
5,620,805
|
Total
assets
|
50,981,701
|
51,723,375
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
Current
liabilities
|
|
|
Trade accounts
payables and accrued liabilities
|
2,363,630
|
1,179,097
|
|
|
|
Non-current
liabilities
|
|
|
Lease
liability
|
820,045
|
1,072,287
|
Total
liabilities
|
3,183,675
|
2,251,384
|
Shareholders'
Equity
|
|
|
Common
shares
|
492,297,041
|
490,259,923
|
Contributed
surplus
|
9,851,991
|
10,383,334
|
Accumulated
deficit
|
(454,351,006)
|
(451,171,266)
|
Total
shareholders' equity
|
47,798,026
|
49,471,991
|
|
|
|
Total liabilities
and shareholders' equity
|
50,981,701
|
51,723,375
|
EcoSynthetix
Inc.
|
|
|
|
|
|
Consolidated
Statements of Operations and Comprehensive Loss
|
|
|
|
|
|
For the three and
twelve months ended December 31, 2021 and 2020
|
|
|
|
|
(expressed in US
dollars)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended December 31,
|
|
Twelve
months ended December 31,
|
|
2021
|
2020
|
|
2021
|
2020
|
|
|
|
|
|
|
Net
sales
|
4,885,420
|
3,343,823
|
|
18,161,891
|
13,662,711
|
|
|
|
|
|
|
Cost of
sales
|
3,872,001
|
2,664,492
|
|
14,190,221
|
10,924,338
|
|
|
|
|
|
|
Gross profit on
sales
|
1,013,419
|
679,331
|
|
3,971,670
|
2,738,373
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
Selling, general and
administrative
|
1,494,155
|
1,204,655
|
|
5,382,396
|
4,333,649
|
Research and
development
|
466,630
|
266,802
|
|
1,831,440
|
1,412,315
|
|
1,960,785
|
1,471,457
|
|
7,213,836
|
5,745,964
|
|
|
|
|
|
|
Loss from
operations
|
(947,366)
|
(792,126)
|
|
(3,242,166)
|
(3,007,591)
|
|
|
|
|
|
|
Net interest
income
|
10,499
|
86,222
|
|
62,426
|
605,497
|
Net loss and
comprehensive loss
|
(936,867)
|
(705,904)
|
|
(3,179,740)
|
(2,402,094)
|
|
|
|
|
|
|
Basic and diluted
loss per common share
|
(0.02)
|
(0.01)
|
|
(0.06)
|
(0.04)
|
Weighted average
number of common shares outstanding
|
57,871,822
|
56,823,364
|
|
57,410,885
|
57,196,584
|
EcoSynthetix
Inc.
|
|
|
|
|
|
Interim
Consolidated Statements of Cash Flows
|
|
|
|
|
|
For the three and
twelve months ended December 31, 2021 and 2020
|
|
|
|
|
(expressed in US
dollars)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended December 31,
|
|
Twelve
months ended December 31,
|
|
2021
|
2020
|
|
2021
|
2020
|
Cash provided by
(used in)
|
|
|
|
|
|
|
|
|
|
|
|
Operating
activities
|
|
|
|
|
|
Net loss and
comprehensive loss
|
(936,867)
|
(705,904)
|
|
(3,179,740)
|
(2,402,094)
|
Items not affecting
cash
|
|
|
|
|
|
Depreciation
|
324,387
|
391,098
|
|
1,380,832
|
1,439,504
|
Share-based
compensation
|
289,998
|
277,394
|
|
937,260
|
783,822
|
Other
|
(20,168)
|
18,450
|
|
60,361
|
(87,486)
|
Changes in non-cash
working capital
|
|
|
|
|
|
Accounts
receivable
|
184,549
|
(665,042)
|
|
(272,807)
|
184,998
|
Inventory
|
466,681
|
271,201
|
|
(31,615)
|
152,390
|
Government grants
receivable
|
15,807
|
(81,990)
|
|
115,542
|
(7,262)
|
Prepaid expenses
|
40,162
|
40,742
|
|
(22,297)
|
6,340
|
Trade accounts payables and
accrued liabilities
|
(75,633)
|
(71,244)
|
|
1,141,956
|
(219,409)
|
Interest on
short-term investments
|
|
|
|
|
|
Interest received on short-term investments
|
-
|
168,484
|
|
358,740
|
1,037,522
|
Accrued interest on short-term investments
|
-
|
(105,251)
|
|
(14,165)
|
(661,549)
|
|
288,916
|
(462,062)
|
|
474,067
|
226,776
|
|
|
|
|
|
|
Investing
activities
|
|
|
|
|
|
Purchase of property,
plant and equipment
|
(34,474)
|
(41,821)
|
|
(379,976)
|
(248,146)
|
Receipts of
government grants related to property, plant and
equipment
|
-
|
-
|
|
67,418
|
-
|
Receipts on mature
short-term investments
|
-
|
30,000,000
|
|
25,000,000
|
75,000,000
|
Purchase of
short-term investments
|
-
|
(20,000,000)
|
|
-
|
(65,000,000)
|
|
(34,474)
|
9,958,179
|
|
24,687,442
|
9,751,854
|
|
|
|
|
|
|
Financing
activities
|
|
|
|
|
|
Payments made on
lease liability
|
(63,608)
|
(49,194)
|
|
(249,246)
|
(192,989)
|
Common shares
repurchased
|
(402,837)
|
(311,158)
|
|
(1,200,835)
|
(1,957,216)
|
Exercise of common
share options
|
1,664,006
|
628,282
|
|
1,924,361
|
719,576
|
|
1,197,561
|
267,930
|
|
474,280
|
(1,430,629)
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange
rate changes on cash
|
23,551
|
39,549
|
|
(46,134)
|
113,447
|
|
|
|
|
|
|
Change in cash
during the period
|
1,475,554
|
9,803,596
|
|
25,589,655
|
8,661,448
|
|
|
|
|
|
|
Cash - Beginning
of period
|
40,751,262
|
6,833,568
|
|
16,637,161
|
7,975,713
|
|
|
|
|
|
|
Cash - End of
period
|
42,226,816
|
16,637,164
|
|
42,226,816
|
16,637,161
|
SOURCE EcoSynthetix Inc.